| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 0 | 5.003 | 13.484 | 31.361 |
| Total Income - EUR | - | - | - | - | 0 | 0 | 0 | 5.003 | 13.490 | 31.377 |
| Total Expenses - EUR | - | - | - | - | 176 | 1.225 | 1.538 | 3.457 | 10.812 | 26.551 |
| Gross Profit/Loss - EUR | - | - | - | - | -176 | -1.225 | -1.538 | 1.546 | 2.678 | 4.826 |
| Net Profit/Loss - EUR | - | - | - | - | -176 | -1.225 | -1.538 | 1.396 | 2.244 | 4.135 |
| Employees | - | - | - | - | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Gaba Labs S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 363 | 0 | 0 | 0 | 998 | 0 |
| Current Assets | - | - | - | - | 65 | 138 | 174 | 2.144 | 9.119 | 15.305 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 110 | 1.915 | 1.249 | 8.927 |
| Cash | - | - | - | - | 65 | 138 | 64 | 228 | 7.870 | 6.378 |
| Shareholders Funds | - | - | - | - | -133 | -1.356 | -2.864 | -1.476 | 772 | 4.903 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 561 | 1.494 | 3.038 | 3.620 | 9.344 | 10.402 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3220 - 3220" | |||||||||
| CAEN Financial Year |
3220
|
|||||||||
Comments - Gaba Labs S.r.l.